Indefinite Delivery Contract SPE2DX15D9315

The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, valued at up to $499,999,999 through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide.

The solicitation materials indicate that DMS Pharmaceutical Group has been awarded numerous delivery orders under this IDC contract vehicle to provide a diverse array of pharmaceutical and medical supplies, such as oncology treatments, contraceptives, auto-injectors, and specialized medications like Xolair, Trikafta, and Keytruda. The delivery orders are predominantly firm fixed-price contracts with no set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains in support of the Department of Defense's healthcare operations.